Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Neurosciences

  • You have access
    Evaluation of glioma tumor volume with 18F-fluciclovine positron emission tomography interpreted in combination with MRI, compared with MRI alone: Results from a prospective phase 3 blinded image evaluation
    Matthew Miller, Karl-Josef Langen, Vikas Prasad, Igor Yakushev, Johannes Gerber, Marcus Bronzel, Tobias Meyer, Albert Chau, Daniel Stevens, Diane Chisholm and Andreas Kluge
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 394;
  • You have access
    Regional brain cholinergic system changes in Parkinson disease with RBD: an 18F-FEOBV PET study
    Prabesh Kanel, Martijn Muller and Nicolaas Bohnen
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1496;
  • You have access
    Analysis of mGluR5 and synaptic density in Alzheimer’s disease: A multi-tracer study
    Adam Mecca, Ming-Kai Chen, Tyler Godek, Joanna Harris, Hugh Bartlett, Takuya Toyonaga, Mika Naganawa, Arash Salardini, Amy Arnsten, Nabeel Nabulsi, Keunpoong Lim, Soheila Najafzadeh, Jim Ropchan, Yiyun Huang, Richard Carson, Stephen Strittmatter and Christopher Van Dyck
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 51;
  • You have access
    Evaluation of [18F]MNI-1126, an18F-labeled SV2A PET tracer in healthy, Parkinson disease and Alzheimer’s disease subjects
    Cristian Constantinescu, Vincent Carroll, Alexandra Gouasmat, Cedric Tresse, David Russell, Roger Gunn, Olivier Barret, Eugenii Rabiner and Kenneth Marek
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 320;
  • You have access
    Establishing imaging patterns on FDG PET/CT for specific antibody sub-types ofAutoimmune Encephalitis
    Vanshika Gupta, Ritu Verma, Rajeev Ranjan, Ethel Belho and Harsh Mahajan
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1473;
  • You have access
    Early 18F-Florapronol brain PET images may be used as additional biomarker such as 18F-FDG brain PET.
    Do-Young Kang, Hyeon Ju Noh, Young Jin Jeong, Hyun Jin Yoon, Hyeon Kang, Kyungwon Park and Jongho Kim
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1477;
  • You have access
    Prognostic value of 11C-methionine PET in patients with IDH wild-type glioma
    Bart Van Dijken, Alfred Ankrah, Gilles Stormezand, Peter Jan van Laar, Rudi Dierckx and Anouk van der Hoorn
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1501;
  • You have access
    PET imaging of [11C](R)(-)NR2B-Me, a novel radioligand for the NR2B subunit of the NMDA receptor, in rhesus macaques
    Rachel Dick, Lisheng Cai, Xuefeng Yan, Jeih-San Liow, Cheryl Morse, Sami Zoghbi, Michael Frankland, Robert Gladding, Victor Pike and Robert Innis
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 115;
  • You have access
    Antioxidative neuroprotective role of iron-gallic acid coordination nanoparticles and PET/MR usage in an ischemia stroke model
    LEI KANG, Dawei Jiang, Dalong NI, Emily Ehlerding, Rongfu Wang and Weibo Cai
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 113;
  • You have access
    Increasing fibrillar amyloidosis is associated with improved cognition and synaptic preservation caused by microglia modulation
    Maximilian Deussing, Tanja Blume, Benedikt Zott, Yuan Shi, Gernot Kleinberger, Carola Focke, Simon Lindner, Franz-Josef Gildehaus, Leonie Beyer, Barbara von Ungern-Sternberg, Peter Bartenstein, Laurence Ozmen, Karlheinz Baumann, Mario Dorostkar, Christian Haass, Helmuth Adelsberger, Axel Rominger, Jochen Herms and Matthias Brendel
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 53;

Pages

  • Previous
  • Next
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 100
SNMMI

© 2025 SNMMI

Powered by HighWire